explore -WSS

explore

author：knowledge 2025-10-01 23:38:48 - browse：78

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Gene therapy denied for Afghan refugee whose father aided U.S.

Wikipedia

WSS

Congress must give Medicare recipients genetic counseling access

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Study suggests new cause of Down syndrome: cells linked to aging

Ascension's ugly legal battle over care for poor patients in Texas

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

At JPM 2024, hospital systems pitch financial strength to investors

knowledge

explore

leisure time

Heart attack and stroke risk calculators need revising

Eye stem cell transplant could help restore vision in injured people

Alkermes shareholders re

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Gene therapy denied for Afghan refugee whose father aided U.S.

Peter Hotez and the public health issue of online harassment

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

JPM pitch from hospitals? Revenue streams outside of patient care

leisure time

Ascension's ugly legal battle over care for poor patients in Texas

Liz Cheney makes 1st public comment since Trump's election interference indictments

Medicare Advantage overpayments discussion gets experts fired up

The pain doctors face in trying to build their families

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Physician assistants need a new name. Here's what it should be

Wikipedia

focus

hotspot

focus